New Zealand markets close in 6 hours 4 minutes

Eli Lilly and Company (LLY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
248.44+3.39 (+1.38%)
At close: 4:03PM EDT
249.10 +0.66 (+0.27%)
After hours: 05:55PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
26,726,300
24,539,800
22,319,500
24,555,700
22,871,300
Cost of revenue
6,878,000
5,483,300
4,721,200
6,430,000
6,070,200
Gross profit
19,848,300
19,056,500
17,598,300
18,125,700
16,801,100
Operating expenses
Research development
6,661,000
6,085,700
5,595,000
5,307,100
5,281,800
Selling general and administrative
6,384,700
6,121,200
6,213,800
6,631,800
7,101,800
Total operating expenses
13,045,700
12,206,900
11,808,800
11,938,900
12,383,600
Operating income or loss
6,802,600
6,849,600
5,789,500
6,186,800
4,417,500
Interest expense
353,500
359,600
400,600
272,100
225,000
Total other income/expenses net
505,000
706,900
-203,400
-2,280,300
-2,162,400
Income before tax
6,976,600
7,229,900
5,265,900
3,795,700
2,197,400
Income tax expense
905,900
1,036,200
628,000
563,700
2,401,500
Income from continuing operations
6,070,700
6,193,700
4,637,900
3,232,000
-204,100
Net income
6,070,700
6,193,700
8,318,400
3,232,000
-204,100
Net income available to common shareholders
6,070,700
6,193,700
8,318,400
3,232,000
-204,100
Basic EPS
-
6.47
8.69
3.14
-0.19
Diluted EPS
-
6.47
8.69
3.13
-0.19
Basic average shares
-
956,590
957,526
1,027,721
1,052,023
Diluted average shares
-
956,590
957,526
1,033,667
1,052,023
EBITDA
-
8,913,400
6,899,100
5,676,800
3,989,700